← Back to Clinical Trials
Recruiting NCT06987552

Single-Port RAS Using Da Vinci SP Surgical System for UTUC Patients

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Upper Tract Urothelial Cancer
Sponsor National Taiwan University Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 25
Sex ALL
Min Age 20 Years
Max Age N/A
Start Date 2024-12-24
Completion 2025-06-30
Interventions
Da Vinci SP Surgical System

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

To evaluate patient-reported outcomes of radical nephroureterectomy using single-port robotic surgery

Eligibility Criteria

Inclusion Criteria: * Age 20 years or more * Histologically or cytologically diagnosed upper tract urothelial cancer * Fitting indications of radical nephroureterectomy and ipsilateral bladder cuff resection, and deemed feasible for robotic surgery * ASA physical status classification 1-2 and adequate organ function * Patients willing and able to comply with study protocol requirements and follow-up * With informed consent Exclusion Criteria: * Synchronous bladder cancer * Distant metastasis of cancer * BMI ≥30 or BMI \<18.5 * Unable to tolerate lateral decubitus or Trendelenburg position (relative contra-indication) * Severe adhesion due to prior abdominopelvic surgery (relative contra-indication) * Previous radiation treatment to the pelvic area * Active infectious disease * Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic interventions, such as: severe heart disease (NYHA functional class III-IV) or severe lung disease (GOLD Group

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}